Goldman Sachs’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.79M Buy
838,233
+429,891
+105% +$3.32M ﹤0.01% 3559
2025
Q4
$3.6M Buy
408,342
+68,641
+20% +$378K ﹤0.01% 4057
2025
Q3
$1.7M Sell
339,701
-67,030
-16% -$310K ﹤0.01% 4620
2025
Q2
$1.92M Sell
406,731
-287,121
-41% -$1.26M ﹤0.01% 4216
2025
Q1
$3.18M Sell
693,852
-93,965
-12% -$438K ﹤0.01% 3785
2024
Q4
$3.77M Buy
787,817
+27,459
+4% +$132K ﹤0.01% 3735
2024
Q3
$3.57M Buy
760,358
+403,812
+113% +$2.16M ﹤0.01% 3656
2024
Q2
$2.01M Sell
356,546
-148,839
-29% -$769K ﹤0.01% 3909
2024
Q1
$2.08M Buy
505,385
+44,172
+10% +$177K ﹤0.01% 3841
2023
Q4
$1.95M Sell
461,213
-1,211,363
-72% -$4.89M ﹤0.01% 3946
2023
Q3
$7.23M Sell
1,672,576
-430,915
-20% -$2.39M ﹤0.01% 2665
2023
Q2
$13.9M Buy
2,103,491
+452,554
+27% +$2.9M ﹤0.01% 2155
2023
Q1
$11.2M Buy
1,650,937
+159,703
+11% +$1.12M ﹤0.01% 2317
2022
Q4
$11M Sell
1,491,234
-213,680
-13% -$2.08M ﹤0.01% 2496
2022
Q3
$16.8M Sell
1,704,914
-127,767
-7% -$1.35M ﹤0.01% 2017
2022
Q2
$20M Sell
1,832,681
-47,819
-3% -$495K 0.01% 1894
2022
Q1
$21.3M Buy
1,880,500
+179,244
+11% +$2.36M 0.01% 2005
2021
Q4
$26.7M Buy
1,701,256
+885,431
+109% +$15.4M 0.01% 1864
2021
Q3
$14M Buy
815,825
+157,413
+24% +$2.76M ﹤0.01% 2395
2021
Q2
$14.2M Buy
658,412
+112,063
+21% +$2.01M ﹤0.01% 2361
2021
Q1
$8.21M Sell
546,349
-259,988
-32% -$4.21M ﹤0.01% 2725
2020
Q4
$10.6M Buy
806,337
+9,247
+1% +$111K ﹤0.01% 2406
2020
Q3
$7.7M Buy
797,090
+277,706
+53% +$2.97M ﹤0.01% 2549
2020
Q2
$5.94M Sell
519,384
-115,163
-18% -$1.3M ﹤0.01% 2669
2020
Q1
$6.57M Sell
634,547
-36,839
-5% -$457K ﹤0.01% 2422
2019
Q4
$11M Sell
671,386
-307,731
-31% -$4.65M ﹤0.01% 2364
2019
Q3
$13M Buy
979,117
+325,430
+50% +$4.54M ﹤0.01% 2138
2019
Q2
$9.21M Sell
653,687
-177,048
-21% -$2.82M ﹤0.01% 2422
2019
Q1
$15.3M Buy
830,735
+169,200
+26% +$3.86M 0.01% 2095
2018
Q4
$17.3M Buy
661,535
+73,456
+12% +$1.73M 0.01% 1924
2018
Q3
$13.5M Buy
588,079
+383,660
+188% +$7.83M ﹤0.01% 2222
2018
Q2
$3.89M Sell
204,419
-25,394
-11% -$425K ﹤0.01% 3135
2018
Q1
$3.87M Buy
229,813
+39,955
+21% +$669K ﹤0.01% 3099
2017
Q4
$2.89M Sell
189,858
-236,250
-55% -$3.51M ﹤0.01% 3485
2017
Q3
$7.63M Buy
426,108
+105,018
+33% +$1.76M ﹤0.01% 2789
2017
Q2
$5.23M Sell
321,090
-7,778
-2% -$112K ﹤0.01% 3018
2017
Q1
$4.6M Sell
328,868
-144,041
-30% -$2.05M ﹤0.01% 3002
2016
Q4
$7.54M Sell
472,909
-367,253
-44% -$5.9M ﹤0.01% 2684
2016
Q3
$14M Buy
840,162
+492,276
+142% +$6.63M 0.01% 2180
2016
Q2
$3.89M Buy
347,886
+34,980
+11% +$339K ﹤0.01% 3068
2016
Q1
$2.62M Buy
312,906
+253,644
+428% +$2.08M ﹤0.01% 3241
2015
Q4
$552K Sell
59,262
-77,268
-57% -$771K ﹤0.01% 4835
2015
Q3
$1.54M Sell
136,530
-2,699,956
-95% -$33M ﹤0.01% 4050
2015
Q2
$36M Sell
2,836,486
-1,368,906
-33% -$14.8M 0.01% 1360
2015
Q1
$39.1M Buy
4,205,392
+4,026,749
+2,254% +$45.5M 0.02% 1281
2014
Q4
$2.56M Sell
178,643
-550,305
-75% -$6.51M ﹤0.01% 3598
2014
Q3
$7.57M Buy
728,948
+202,477
+38% +$2.65M ﹤0.01% 2611
2014
Q2
$8.52M Buy
526,471
+197,191
+60% +$2.63M ﹤0.01% 2513
2014
Q1
$5.35M Sell
329,280
-171,469
-34% -$2.44M ﹤0.01% 2944
2013
Q4
$6.21M Buy
500,749
+157,523
+46% +$1.58M ﹤0.01% 2832
2013
Q3
$3.76M Buy
343,226
+322,274
+1,538% +$3.44M ﹤0.01% 3249
2013
Q2
$169K Buy
+20,952
New +$141K ﹤0.01% 5676

Other funds holding VNDA